Analysis of 4-Bromo-2,5-DimethoxyphenethylamineAbuser's Urine: Identification and Quantitation of Urinary Metabolites

Journal of Forensic Sciences

Volumn 58, Issue 1, 2013, Pages 279-287

  Kanamori, Tatsuyuki ^a   Nagasawa, Kyoko ^b   Kuwayama, Kenji ^a   Tsujikawa, Kenji ^a   Iwata, Yuko T ^a   Inoue, Hiroyuki ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

^b Shizuoka Prefectural Police Headquarters   (Japan)

Author keywords

2C B; Forensic science; Gas chromatography mass spectrometry; Human; Metabolism; Metabolite; Urine

Indexed keywords

2 (4 BROMO 2,5 DIMETHOXYPHENYL)ETHYLAMINE; 2-(4-BROMO-2,5-DIMETHOXYPHENYL)ETHYLAMINE; 4 BROMO 2 HYDROXY 5 METHOXYPHENYLACETIC ACID; 4 BROMO 2,5 DIMETHOXYPHENYLACETIC ACID; 4 BROMO 2,5 DIMETHOXYPHENYLETHYL ALCOHOL; 4-BROMO-2,5-DIMETHOXYPHENYLACETIC ACID; 4-BROMO-2,5-DIMETHOXYPHENYLETHYL ALCOHOL; 4-BROMO-2-HYDROXY-5-METHOXYPHENYLACETIC ACID; DRUG DERIVATIVE; HOMOVERATRYLAMINE; PHENETHYL ALCOHOL; PHENYLACETIC ACID DERIVATIVE; PSYCHEDELIC AGENT;

ADDICTION; ARTICLE; CASE REPORT; FORENSIC TOXICOLOGY; HUMAN; MASS FRAGMENTOGRAPHY; METHODOLOGY; SUBSTANCE ABUSE; URINE;

DIMETHOXYPHENYLETHYLAMINE; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALLUCINOGENS; HUMANS; PHENYLACETATES; PHENYLETHYL ALCOHOL; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84872390206     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2012.02289.x     Document Type: Article

References (18)

1. Shulgin AT, Carter MF. Centrally active phenethylamines. Psychopharmacol Commun 1975;1:93-8.
2. Ragan FA Jr, Hite SA, Samuels MS, Garey RE. 4-Bromo-2, 5-dimethoxyphenethylamine: identification of a new street drug. J Anal Toxicol 1985;9:91-3.
3. Giroud C, Augsburger M, Rivier L, Mangin P, Sadeghipour F, Varesio E, et al. 2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market. J Anal Toxicol 1998;22:345-54.
4. de Boer D, Gijzels MJ, Bosman IJ, Maes RA. More data about the new psychoactive drug 2C-B. J Anal Toxicol 1999;23:227-8.
5. Kanamori T, Inoue H, Iwata Y, Ohmae Y, Kishi T. In vivo metabolism of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. J Anal Toxicol 2002;26:61-6.
6. Theobald DS, Fritschi G, Maurer HH. Studies on the toxicological detection of the designer drug 4-bromo-2, 5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007;846:374-7.
7. Carmo H, de Boer D, Remião F, Carvalho F, dos Reys LA, de Lourdes Bastos M. Metabolism of the designer drug 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in mice, after acute administration. J Chromatogr B Analyt Technol Biomed Life Sci 2004;811:143-52.
8. Kanamori T, Tsujikawa K, Ohmae Y, Iwata YT, Inoue H, Kishi T, et al. A study of the metabolism of methamphetamine and 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Sci Int 2005;148:131-7.
9. Carmo H, Hengstler JG, Boer DD, Ringel M, Remião F, Carvalho F, et al. Metabolic pathways of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. Toxicology 2005;206:75-89.
10. Theobald DS, Maurer HH. Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series). Biochem Pharmacol 2007;73:287-97.
11. Shulgin A, Shulgin A. 2C-B; 4-bromo-2, 5-dimethoxyphenethylamine. In: Joy D, editor. PIHKAL, a chemical love story. Berkeley, CA: Transform Press, 1991;503-6.
12. Shulgin A, Shulgin A. 2C-I; 2, 5-dimethoxy-4-iodophenethylamine. In: Joy D, editor. PIHKAL, a chemical love story. Berkeley, CA: Transform Press, 1991;539-42.
13. Kanamori T, Kuwayama K, Tsujikawa K, Miyaguchi H, Iwata YT, Inoue H. Synthesis and identification of urinary metabolites of 4-iodo-2, 5-dimethoxyphenethylamine. J Forensic Sci 2011;56(5):1319-23.
14. Panoutsopoulos GI, Kouretas D, Gounaris EG, Beedham C. Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde. Basic Clin Pharmacol Toxicol 2004;95:273-9.
15. Mårdh G, Vallee BL. Human class I alcohol dehydrogenases catalyze the interconversion of alcohols and aldehydes in the metabolism of dopamine. Biochemistry 1986;25:7279-82.
16. Kanamori T, Tsujikawa K, Ohmae Y, Iwata Y, Inoue H, Inouye Y, et al. Excretory profile of 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in rat. J Health Sci 2003;49:166-9.
17. Leonardi ET, Azmitia EC. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 1994;10:231-8.
18. Van LM, Heydari A, Yang J, Hargreaves J, Rowland-Yeo K, Lennard MS, et al. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy). J Psychopharmacol 2006;20:834-41.